Diana Shuster

Diana Shuster, PhD, currently serves as Vice President of Clinical Sciences at CenExel, beginning in January 2024. Previously, from May 2021 to January 2024, Diana held the position of Senior Director of Clinical Pharmacology at Recursion, where responsibilities included leading Phase 2 oncology projects and overseeing early development programs in rare diseases and oncology. Prior experience includes Senior Director roles at PRA Health Sciences and Director of Scientific Affairs at AbbVie, focusing on a range of clinical studies and pharmacokinetic modeling. Diana's academic background includes a PhD in Pharmaceutics from the University of Washington, where research involved modeling pharmacokinetics in pregnant women with gestational diabetes. Earlier work also included a contract position at Seattle Genetics, investigating chemotherapy resistance mechanisms. Diana holds a B.S. in Biochemistry from Ashland University.